Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label lacosamide follow-on study in painful distal diabetic neuropathy
2004-000551-42Phase 3Completed
- Sponsor
- Schwarz Pharma
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lacosamide in Diabetic Peripheral Neuropathy (DPN) (2 arms), sponsored by Schwarz Pharma. Primary endpoint: Adverse events. Started Aug 2006; status: completed.
02
Drugs
lacosamide
03
Conditions
Diabetic Peripheral Neuropathy (DPN)
Beyond the preview
Go deeper on 2004-000551-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000551-42.